Form 4: ImmunityBio Chief Accounting Officer Reports Stock Transactions
SEC Form 4 Filing
Regan J. Lauer, Chief Accounting Officer of ImmunityBio, Inc., reports the vesting and subsequent disposal of shares to cover tax obligations.
Summary
- On February 22, 2025, Regan J. Lauer, the Chief Accounting Officer of ImmunityBio, Inc., had restricted stock units (RSUs) vest.
- A total of 4,065 shares were acquired upon vesting of the RSUs.
- Simultaneously, 1,669 shares were disposed of at a price of $3.42 to cover tax obligations related to the vesting.
- Following these transactions, Lauer directly owns 110,258 shares of ImmunityBio common stock and 8,130 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative implications for the company's performance.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the trading activities of company executives.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they represent a small percentage of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 02/22/2024 | Vesting commencement date for the RSU award. |
| 02/22/2025 | Date of RSU vesting and stock transactions. |
| 02/25/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.